Market Structure, Emerging Trends, and Key Player Analysis in the Antimicrobial Resistance (AMR) Genotyping Panels Market

The antimicrobial resistance (AMR) genotyping panels market is emerging as a critical segment within infectious disease diagnostics, driven by technological advancements and growing global health concerns. As resistance to antibiotics increases, the need for precise and rapid detection tools becomes essential to managing and controlling infections effectively. This overview explores the market's projected growth, key players, evolving trends, and segmentation to provide a clear understanding of its future trajectory.

Antimicrobial Resistance Genotyping Panels Market Value Forecast Through 2030
The AMR genotyping panels market is set to experience substantial growth in the coming years. It is anticipated to reach a valuation of $2.81 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.1%. This upward trend is largely driven by greater investments in infectious disease diagnostics, the mounting demand for fast point-of-care testing, and the broadening scope of genomic epidemiology programs. Additional factors contributing to this growth include the integration of AMR data analytics and increased regulatory emphasis on resistance monitoring and surveillance.

Download a free sample of the antimicrobial resistance (amr) genotyping panels market report:
https://www.thebusinessresearchcompany.com/report/global-antimicrobial-resistance-amr-genotyping-panels-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Factors Supporting Market Growth in AMR Genotyping Panels
One of the key drivers for the rising adoption of AMR genotyping panels is the growing need for rapid and accurate detection methods to combat antibiotic resistance effectively. This demand is heightened as healthcare systems worldwide prioritize early identification of resistant pathogens to improve patient outcomes. Furthermore, the expansion of hospital-based AMR testing facilities is playing a critical role in accelerating market penetration.

Another significant influence is the technological advancement in multiplex resistance detection panels and molecular diagnostics. These innovations allow simultaneous identification of multiple resistance genes, thereby enhancing diagnostic efficiency. The continuous integration of genomic surveillance tools into routine testing workflows also supports the market's expansion by enabling real-time tracking of resistance patterns.

The antimicrobial resistance (AMR) genotyping panels market is emerging as a critical segment within infectious disease diagnostics, driven by technological advancements and growing global health concerns. As resistance to antibiotics increases, the need for precise and rapid detection tools becomes essential to managing and controlling infections effectively. This overview explores the market's projected growth, key players, evolving trends, and segmentation to provide a clear understanding of its future trajectory.

Antimicrobial Resistance Genotyping Panels Market Value Forecast Through 2030
The AMR genotyping panels market is set to experience substantial growth in the coming years. It is anticipated to reach a valuation of $2.81 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.1%. This upward trend is largely driven by greater investments in infectious disease diagnostics, the mounting demand for fast point-of-care testing, and the broadening scope of genomic epidemiology programs. Additional factors contributing to this growth include the integration of AMR data analytics and increased regulatory emphasis on resistance monitoring and surveillance.

Download a free sample of the antimicrobial resistance (amr) genotyping panels market report:
https://www.thebusinessresearchcompany.com/report/global-antimicrobial-resistance-amr-genotyping-panels-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Factors Supporting Market Growth in AMR Genotyping Panels
One of the key drivers for the rising adoption of AMR genotyping panels is the growing need for rapid and accurate detection methods to combat antibiotic resistance effectively. This demand is heightened as healthcare systems worldwide prioritize early identification of resistant pathogens to improve patient outcomes. Furthermore, the expansion of hospital-based AMR testing facilities is playing a critical role in accelerating market penetration.

Another significant influence is the technological advancement in multiplex resistance detection panels and molecular diagnostics. These innovations allow simultaneous identification of multiple resistance genes, thereby enhancing diagnostic efficiency. The continuous integration of genomic surveillance tools into routine testing workflows also supports the market's expansion by enabling real-time tracking of resistance patterns.

Leading Corporations Powering the AMR Genotyping Panels Industry
The antimicrobial resistance genotyping panels market is populated by several influential companies driving innovation and adoption. Notable names include Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., and OpGen Inc.

Strategic Acquisition Enhances bioMérieux's Capabilities in AMR Diagnostics
In June 2025, bioMérieux, a leading French provider of in vitro diagnostics solutions, acquired Day Zero Diagnostics' assets for $25 million. This strategic move aimed to boost bioMérieux's next-generation sequencing (NGS) and rapid AMR diagnostic offerings to better address infectious disease challenges. Day Zero Diagnostics, a US-based firm, specializes in rapid whole-blood sample preparation, genome sequencing, and machine-learning analytics to identify pathogens and profile antibiotic resistance swiftly and accurately.

Emerging Trends Shaping the Future of AMR Genotyping Panels Globally
The market is witnessing a shift toward AI-integrated automated compounding systems designed to improve the precision and safety of sterile medication preparation. For example, in August 2025, Omnicell, a US health tech company, launched an AI-enhanced upgrade to its intravenous (IV) compounding platform. This advanced system incorporates AI-driven quality assurance tools that continuously monitor compounding processes, automatically detecting deviations to minimize human errors, increase efficiency, and uphold medication quality standards in pharmacies.

Additional innovations in AI-powered robotics and cloud-based monitoring systems are set to revolutionize AMR testing and compounding workflows. These technologies offer unprecedented levels of automation, real-time oversight, and data accuracy, which are vital in managing antimicrobial resistance more effectively in healthcare settings.

Detailed Segmentation of the AMR Genotyping Panels Market
The AMR genotyping panels market is categorized into several important segments for a comprehensive analysis:

1) By Product Type:
- Custom Panels
- Pre-Designed Panels

2) By Technology:
- Polymerase Chain Reaction (PCR)-Based
- Microarray-Based
- Next-Generation Sequencing (NGS)-Based
- Other Technologies

3) By Application:
- Clinical Diagnostics
- Research
- Drug Development
- Other Applications

4) By End-User:
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End-Users

Within product types, custom panels are further divided into pathogen-specific panels, resistance gene-focused panels, multiplex detection panels, targeted mutation panels, and research application panels. Meanwhile, pre-designed panels include standardized diagnostic panels, broad-spectrum resistance panels, disease-specific panels, commercially validated panels, and ready-to-use screening panels, each catering to diverse diagnostic needs and research purposes.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.